Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $183.70 million. The enterprise value is $161.75 million.
Important Dates
The next estimated earnings date is Friday, May 8, 2026, before market open.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 80.57 million shares outstanding. The number of shares has decreased by -3.10% in one year.
| Current Share Class | 80.57M |
| Shares Outstanding | 80.57M |
| Shares Change (YoY) | -3.10% |
| Shares Change (QoQ) | -1.61% |
| Owned by Insiders (%) | 10.54% |
| Owned by Institutions (%) | 23.95% |
| Float | 72.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.60 |
| PS Ratio | 3.48 |
| Forward PS | 2.32 |
| PB Ratio | 3.80 |
| P/TBV Ratio | 3.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.51 |
| Quick Ratio | 1.50 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.62 |
Financial Efficiency
Return on equity (ROE) is -14.44% and return on invested capital (ROIC) is -18.97%.
| Return on Equity (ROE) | -14.44% |
| Return on Assets (ROA) | -4.41% |
| Return on Invested Capital (ROIC) | -18.97% |
| Return on Capital Employed (ROCE) | -9.85% |
| Weighted Average Cost of Capital (WACC) | 4.07% |
| Revenue Per Employee | $233,381 |
| Profits Per Employee | -$29,221 |
| Employee Count | 226 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.95 |
Taxes
In the past 12 months, PLX has paid $996,000 in taxes.
| Income Tax | 996,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.09 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.62 |
| 200-Day Moving Average | 2.04 |
| Relative Strength Index (RSI) | 45.30 |
| Average Volume (20 Days) | 1,023,433 |
Short Selling Information
The latest short interest is 4.38 million, so 5.43% of the outstanding shares have been sold short.
| Short Interest | 4.38M |
| Short Previous Month | 4.53M |
| Short % of Shares Out | 5.43% |
| Short % of Float | 6.08% |
| Short Ratio (days to cover) | 3.80 |
Income Statement
In the last 12 months, PLX had revenue of $52.74 million and -$6.60 million in losses. Loss per share was -$0.08.
| Revenue | 52.74M |
| Gross Profit | 6.86M |
| Operating Income | -5.50M |
| Pretax Income | -5.61M |
| Net Income | -6.60M |
| EBITDA | -4.04M |
| EBIT | -5.50M |
| Loss Per Share | -$0.08 |
Full Income StatementBalance Sheet
The company has $30.27 million in cash and $8.32 million in debt, with a net cash position of $21.95 million or $0.27 per share.
| Cash & Cash Equivalents | 30.27M |
| Total Debt | 8.32M |
| Net Cash | 21.95M |
| Net Cash Per Share | $0.27 |
| Equity (Book Value) | 48.23M |
| Book Value Per Share | 0.60 |
| Working Capital | 40.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.99 million and capital expenditures -$1.64 million, giving a free cash flow of -$13.63 million.
| Operating Cash Flow | -11.99M |
| Capital Expenditures | -1.64M |
| Depreciation & Amortization | 1.47M |
| Net Borrowing | n/a |
| Free Cash Flow | -13.63M |
| FCF Per Share | -$0.17 |
Full Cash Flow StatementMargins
Gross margin is 13.01%, with operating and profit margins of -10.43% and -12.52%.
| Gross Margin | 13.01% |
| Operating Margin | -10.43% |
| Pretax Margin | -10.63% |
| Profit Margin | -12.52% |
| EBITDA Margin | -7.65% |
| EBIT Margin | -10.43% |
| FCF Margin | n/a |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.10% |
| Shareholder Yield | 3.10% |
| Earnings Yield | -3.59% |
| FCF Yield | -7.42% |
Analyst Forecast
The average price target for PLX is $12.00, which is 426.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 426.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PLX has an Altman Z-Score of -2.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.76 |
| Piotroski F-Score | 2 |
